Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Urinary Metabolomics Validates Metabolic Differentiation Between Renal Cell Carcinoma Stages and Reveals a Unique Metabolic Profile for Oncocytomas.

Falegan OS, Arnold Egloff SA, Zijlstra A, Hyndman ME, Vogel HJ.

Metabolites. 2019 Jul 24;9(8). pii: E155. doi: 10.3390/metabo9080155.

2.

Urine and Serum Metabolomics Analyses May Distinguish between Stages of Renal Cell Carcinoma.

Falegan OS, Ball MW, Shaykhutdinov RA, Pieroraio PM, Farshidfar F, Vogel HJ, Allaf ME, Hyndman ME.

Metabolites. 2017 Feb 3;7(1). pii: E6. doi: 10.3390/metabo7010006.

3.

High Aerobic Capacity Mitigates Changes in the Plasma Metabolomic Profile Associated with Aging.

Falegan OS, Vogel HJ, Hittel DS, Koch LG, Britton SL, Hepple RT, Shearer J.

J Proteome Res. 2017 Feb 3;16(2):798-805. doi: 10.1021/acs.jproteome.6b00796. Epub 2016 Dec 19.

PMID:
27936752

Supplemental Content

Loading ...
Support Center